Cytokines affecting CD4+T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells. 2017

Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
Immune Tolerance Group, Faculty of Medicine, University of New South Wales Australia, Sydney, NSW, Australia; Ingham Institute, Liverpool, NSW, Australia. Electronic address: b.hall@unsw.edu.au.

CD4+T cells mediate antigen-specific allograft tolerance, but die in culture without activated lymphocyte derived cytokines. Supplementation of the media with cytokine rich supernatant, from ConA activated spleen cells, preserves the capacity of tolerant cells to transfer tolerance and suppress rejection. rIL-2 or rIL-4 alone are insufficient to maintain these cells, however. We observed that activation of naïve CD4+CD25+FOXP3+Treg with alloantigen and the Th2 cytokine rIL-4 induces them to express interleukin-5 specific receptor alpha (IL-5Rα) suggesting that IL-5, a Th2 cytokine that is produced later in the immune response may promote tolerance mediating Treg. This study examined if recombinant IL-5(rIL-5) promoted survival of tolerant CD4+, especially CD4+CD25+T cells. CD4+T cells, from DA rats tolerant to fully allogeneic PVG heart allografts surviving over 100days without on-going immunosuppression, were cultured with PVG alloantigen and rIL-5. The ability of these cells to adoptively transfer tolerance to specific-donor allograft and suppress normal CD4+T cell mediated rejection in adoptive DA hosts was examined. Tolerant CD4+CD25+T cells' response to rIL-5 and expression of IL-5Rα was also assessed. rIL-5 was sufficient to promote transplant tolerance mediating CD4+T cells' survival in culture with specific-donor alloantigen. Tolerant CD4+T cells cultured with rIL-5 retained the capacity to transfer alloantigen-specific tolerance and inhibited naïve CD4+T cells' capacity to effect specific-donor graft rejection. rIL-5 promoted tolerant CD4+CD25+T cells' proliferation in vitro when stimulated with specific-donor but not third-party stimulator cells. Tolerant CD4+CD25+T cells expressed IL-5Rα. This study demonstrated that IL-5 promoted the survival of alloantigen-specific CD4+CD25+T cells that mediate transplant tolerance.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015848 Interleukin-5 A cytokine that promotes differentiation and activation of EOSINOPHILS. It also triggers activated B-LYMPHOCYTES to differentiate into IMMUNOGLOBULIN-secreting cells. B-Cell Growth Factor-II,Eosinophil Differentiation Factor,IL-5,T-Cell Replacing Factor,BCGF-II,Differentiation Factor, Eosinophil,IL5,T-Cell-Replacing Factor,B Cell Growth Factor II,Interleukin 5,Replacing Factor, T-Cell,T Cell Replacing Factor
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D023001 Transplantation Tolerance An induced state of non-reactivity to grafted tissue from a donor organism that would ordinarily trigger a cell-mediated or humoral immune response. Graft Tolerance,Allograft Tolerance,Tolerance, Allograft,Tolerance, Graft,Tolerance, Transplantation

Related Publications

Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
May 2009, International immunopharmacology,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
January 2018, Scientific reports,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
January 2007, Blood,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
March 2017, Cytokine,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
January 2003, Transplant immunology,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
August 2006, Immunological reviews,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
July 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
March 2012, Transplantation,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
December 2006, International immunopharmacology,
Bruce M Hall, and Karren M Plain, and Giang T Tran, and Nirupama D Verma, and Catherine M Robinson, and Masaru Nomura, and Rochelle Boyd, and Suzanne J Hodgkinson
December 2004, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!